Empowered Patient Podcast

Welcome to the Empowered Patient Podcast with Karen Jagoda. This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape. Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes Value-based healthcare Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Treatment and Prevention of Cytomegalovirus Following Organ Transplantation with Dr. Neil Inhaber Takeda TRANSCRIPT

Download PDF

Sep 29, 2026

Dr. Neil Inhaber, VP and Head of Global Medical Affairs at Takeda, highlights the complexities of cytomegalovirus (CMV) infection following organ transplantation when a patient's immune system is suppressed. Managing post-transplant CMV is particularly challenging because treatments must balance the risk of...

Treatment and Prevention of Cytomegalovirus Following Organ Transplantation with Dr. Neil Inhaber Takeda

Sep 29, 2026

Novel Antiviral Drug Shows Promise Treating Norovirus with Dr. Sam Lee Cocrystal Pharma TRANSCRIPT

Download PDF

Dec 18, 2023

Dr. Sam Lee, Co-CEO of Cocrystal Pharma, discusses novel antiviral therapeutics to treat norovirus. This highly contagious virus causes acute gastroenteritis, and there is no known treatment or vaccine. Cocrystal is developing a compound that targets the essential enzymes of the virus, showing promising results...

Novel Antiviral Drug Shows Promise Treating Norovirus with Dr. Sam Lee Cocrystal Pharma

Dec 18, 2023

Drug Development Platform Creating Novel Antiviral Therapeutics for Pandemics and Seasonal Influenza with Sam Lee and Jim Martin Cocrystal Pharma TRANSCRIPT

Download PDF

May 8, 2022

Sam Lee, interim Co-CEO and President, and Jim Martin, interim Co-CEO and CFO of Cocrystal Pharma. They're a clinical stage biotech company using their proprietary drug development platform to create novel antiviral therapeutics to treat seasonal influenza and pandemic viral infections like COVID-19.

Jim explains,...